These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 4870040)

  • 21. [Clinical pharmacology in the USA. V. Studies of drugs in humans, phase 3].
    Spechtmeyer H
    Med Welt; 1968 Sep; 39():2074-7. PubMed ID: 4887317
    [No Abstract]   [Full Text] [Related]  

  • 22. The evaluation of drugs.
    McMichael J
    J Ir Med Assoc; 1968 Oct; ():Suppl 1:26-8. PubMed ID: 4882891
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical evaluation of drugs in man and animals.
    Uvarov O
    Proc R Soc Med; 1968 Jun; 61(6):569-74. PubMed ID: 4873871
    [No Abstract]   [Full Text] [Related]  

  • 24. [Necessity of clinically controlled studies for the development of new drugs].
    Lüthy E; Joyce CR
    Ther Umsch; 1971 Apr; 28(4):246-9. PubMed ID: 4930184
    [No Abstract]   [Full Text] [Related]  

  • 25. [Drugs and the market].
    Tognoni G
    Assist Inferm Ric; 2008; 27(4):226-9. PubMed ID: 19260373
    [No Abstract]   [Full Text] [Related]  

  • 26. Principles for the clinical evaluation of drugs. Report of a WHO Scientific Group.
    World Health Organ Tech Rep Ser; 1968; 403():1-32. PubMed ID: 4972959
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical evidence for potentiation of synergistically acting drugs--a short communication.
    Pöch G
    Int J Clin Pharmacol Ther Toxicol; 1982 Aug; 20(8):380-1. PubMed ID: 7118325
    [No Abstract]   [Full Text] [Related]  

  • 28. Translating pharmacogenomics: challenges on the road to the clinic.
    Swen JJ; Huizinga TW; Gelderblom H; de Vries EG; Assendelft WJ; Kirchheiner J; Guchelaar HJ
    PLoS Med; 2007 Aug; 4(8):e209. PubMed ID: 17696640
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical pharmacology in the USA. IV. Examination of drugs in humans during phases I and II].
    Spechtmeyer H
    Med Welt; 1968 Sep; 38():2019-23. PubMed ID: 4889795
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical drug research in children: current international guidelines. Committee for Proprietary Medicinal Products].
    Ruys-Dudok van Heel I; Cohen AF; Wit JM; van der Heijden AJ; van den Anker JN; van Meurs AH
    Ned Tijdschr Geneeskd; 1998 Jan; 142(1):6-9. PubMed ID: 9556981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Using disease progression models as a tool to detect drug effect.
    Mould DR; Denman NG; Duffull S
    Clin Pharmacol Ther; 2007 Jul; 82(1):81-6. PubMed ID: 17507925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical and pharmacological problems in the evaluation of drugs].
    Vrhovac B
    Lijec Vjesn; 1965 Jun; 87(6):673-5. PubMed ID: 5322518
    [No Abstract]   [Full Text] [Related]  

  • 33. [Voluntary reporting of adverse reactions to drugs].
    Laporte JR; Porta M; Capellà D; Frati ME
    Med Clin (Barc); 1982 Oct; 79(6):287-91. PubMed ID: 6755090
    [No Abstract]   [Full Text] [Related]  

  • 34. [Many indispensible drugs are not studied in pediatrics. Russian pill roulette with children?. Interview by Dr. Stephanie Czajka].
    Seyberth H
    MMW Fortschr Med; 2000 Feb; 142(7):14. PubMed ID: 10832328
    [No Abstract]   [Full Text] [Related]  

  • 35. Improving how we evaluate the toxicity of approved drugs.
    Reidenberg MM
    Clin Pharmacol Ther; 2006 Jul; 80(1):1-6. PubMed ID: 16815311
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical research with new drugs].
    Oberholzer RJ
    Pharm Acta Helv; 1968 Sep; 43(9):550-71. PubMed ID: 4887984
    [No Abstract]   [Full Text] [Related]  

  • 37. The Food and Drug Administration perspective: use of an investigational drug in a medical emergency.
    Schultheis LW; Rappaport BA
    Anesth Analg; 2007 Mar; 104(3):479-80. PubMed ID: 17312189
    [No Abstract]   [Full Text] [Related]  

  • 38. Problems of new drugs.
    Tornya PT
    Med J Aust; 1970 Jun; 1(25):1266. PubMed ID: 4918052
    [No Abstract]   [Full Text] [Related]  

  • 39. [Measuring the kidney function in drug trials and during drug therapy].
    Aitio ML
    Duodecim; 1999; 115(21):2358-64. PubMed ID: 11973867
    [No Abstract]   [Full Text] [Related]  

  • 40. What will it take to reap the clinical benefits of pharmacogenomics?
    Evans BJ
    Food Drug Law J; 2006; 61(4):753-94. PubMed ID: 17180771
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.